Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAFV600E inhibition and can be targeted to reduce resistance Article

Serasinghe, MN, Missert, DJ, Asciolla, JJ et al. (2015). Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAFV600E inhibition and can be targeted to reduce resistance . Oncogene, 34(7), 857-867. 10.1038/onc.2014.21

Open Access

cited authors

  • Serasinghe, MN; Missert, DJ; Asciolla, JJ; Podgrabinska, S; Wieder, SY; Izadmehr, S; Belbin, G; Skobe, M; Chipuk, JE

sustainable development goals

authors

publication date

  • February 12, 2015

published in

keywords

  • BAX
  • BH3 DOMAINS
  • BRAF
  • Biochemistry & Molecular Biology
  • Cell Biology
  • DIMERIZATION
  • FAMILY
  • Genetics & Heredity
  • Life Sciences & Biomedicine
  • Oncology
  • PATHWAY
  • POTENT
  • RESPONSES
  • SURVIVAL
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • NATURE PUBLISHING GROUP

start page

  • 857

end page

  • 867

volume

  • 34

issue

  • 7